Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2025 Sep 1.
Published in final edited form as: Respir Med. 2024 Jun 20;231:107719. doi: 10.1016/j.rmed.2024.107719

Racial Differences in Palliative Care and Hospice Among Adults with Chronic Obstructive Pulmonary Disease

Natalia Smirnova 1, Sarah H Cross 2, Amanda Light 3, Dio Kavalieratos 2
PMCID: PMC11298293  NIHMSID: NIHMS2005370  PMID: 38908412

Introduction

Chronic obstructive pulmonary disease (COPD) is a serious respiratory illness associated with debilitating symptoms including breathlessness, fatigue, and anxiety.1,2 Individuals with COPD often experience frequent hospitalizations and high-intensity care at the end-of-life (EOL).3,4 International professional societies recommend palliative approaches in COPD.57 Although people with COPD experience a higher symptom burden and worse functional status than patients with other serious illness such as cancer, people with COPD are less likely to receive specialty palliative care (PC) or hospice and more likely to die in the hospital or the intensive care unit (ICU).813 Furthermore, evidence of inequities within COPD exist. For example, Black individuals and those with lower socioeconomic status are likelier to experience COPD exacerbations and have worse quality of life than White individuals and those with higher socioeconomic status.14,15 However, whether racial and socioeconomic differences exist in COPD at the EOL specifically remains unknown.

Methods

This retrospective cohort study used medical records from individuals aged ≥40 years in the Georgia Death Index (GDI) who died between 2014 and 2018 with International Classification of Diseases (ICD), Tenth Revision codes J42.xx, J43.xx, or J44.xx listed as underlying cause of death, received care from Emory Healthcare, and had a documented spirometry test. We did not review each spirometry value to confirm a diagnosis of COPD, as race-based corrections during the study period may have introduced additional selection bias and worsened disparities in diagnosis.16 However, we restricted our sample to decedents who had undergone spirometry to increase specificity, as spirometric testing is an essential step in the diagnosis of COPD.17,18 Individuals in the GDI were matched to medical records in the Emory University Clinical Data Warehouse using Social Security Number, date of birth, and last name. We determined COPD diagnosis from the GDI. As not all individuals died in an Emory Healthcare hospital, we obtained date of death from the GDI. This study was deemed by the Emory University IRB to not constitute human subjects research as it used decedents’ medical records.

Outcomes were PC consultation (PCC) and hospice order. PCC was determined by the presence of ICD-9 code V66.7 or ICD-10 code Z51.5. To determine PCC timing, we used the date of the first clinical encounter associated with the PCC diagnostic code. Hospice orders were determined by the presence of orders in the medical record. Patient-level independent variables included race, sex, age at death, insurance, death year, spiritual care consult (SCC), and ICU use in the last 30 days. Race and age at death were obtained from the GDI; insurance was obtained from the medical record. Ethnicity was not included due to inconsistent recording. ZIP codes were obtained from the GDI and linked to Rural-Urban Commuting Area Codes to create metropolitan, micropolitan, small town, and rural categories.19 We linked ZIP codes to the social deprivation index (SDI), a composite measure of area-level deprivation based on demographic characteristics from the American Community Survey.20,21 SDI ranges from 1 (lowest) to 100 (highest) and was classified into quartiles: Q1 (1–25), Q2 (26–50), Q3 (51–75), and Q4 (76–100).22

We used Pearson’s 𝑋2 test to evaluate differences in the distribution of decedent characteristics and race. We estimated prevalence ratios (PR) and 95% confidence intervals of each EOL outcome using Poisson regression with robust standard errors adjusting models for sex, age at death, marital status, insurance status, rurality, social deprivation, SCC and ICU use. Analyses were conducted using Stata17 (StataCorp).

Results

Of 1,188 decedents, 80.2% were White (n=953) and 19.8% were Black (n=253). (Table 1). Mean death age was 75.3 years and was lower among Black than White decedents (72.7 vs 76.0 years).

Table 1.

Decedent Characteristics by Race

Characteristics Overall N=1,188 White N=953 (80.2%) Black N=235 (19.8%) White v Black
N % N % N %
Sex .544
Female 621 52.3 494 51.8 127 54.0
Male 567 47.7 459 48.1 108 46.0
Age at Death <.001
Mean (SD) 75.3 (10.4) 76.0 (10.3) 72.7 (10.4)
<54 24 2.02 13 1.3 11 4.9
55–64 177 14.9 137 14.4 40 17.0
65–79 548 46.1 424 44.5 124 52.8
80 + 439 37.0 379 39.8 60 25.5
Marital Status <.001
 Married 597 50.3 513 53.8 84 35.7
 Single 139 11.7 89 9.3 50 21.3
 Divorced/Separated 146 12.3 104 10.9 42 17.9
 Widowed 253 21.3 201 21.1 52 22.1
 Unknown 53 4.5 46 4.8 7 3.0
Insurance .206
Private 396 33.4 315 33.1 81 34.5
Medicare 530 44.7 422 44.3 108 46.0
Medicaid 53 4.5 38 4.0 15 6.4
Miscellaneous 8 0.7 7 0.7 1 0.4
Not Recorded 201 16.9 171 17.9 30 12.8
Rural Urban <.001
Metropolitan 1,001 84.3 776 81.4 225 95.7 <.001
Micropolitan 150 12.6 140 14.7 10 4.3
Small town 21 1.8 21 2.2 0 0.0
Rural 16 1.4 16 1.7 0 0.0
Social Deprivation
Quartile 1 (lowest) 183 15.4 166 17.4 17 7.2
Quartile 2 275 23.2 245 25.7 30 12.8
Quartile 3 409 34.4 358 37.6 51 21.7
Quartile 4 (highest) 321 27.0 184 19.3 137 58.3
End-of-Life Care Use
Palliative Care Consultation (PCC) 284 23.9 201 21.1 83 35.3 <.001
Days from first PCC to death Median (IQR)
58.8 (12.0, 289.4)
Median (IQR)
46.5 (11.7, 219.1)
Median (IQR)
101.3 (13.3, 519.0)
.049
Hospice Order 203 17.1 149 15.6 54 23.0 .007
Spiritual Care Consultation (SCC) 374 31.5 264 27.7 110 46.8 <.001
ICU in last 30 days 123 10.4 75 7.9 48 20.4 <.001
Hospitalization in last 90 days 296 24.9 206 21.6 90 38.3 <.001
Hospital Death 58 4.9 35 3.7 23 9.8 <.001

Note: P-value determined using X2, t-test, and Wilcoxon rank sum tests. Column percentages presented.

Nearly 24% (n=284) of individuals received a PCC and 17% (n=203) received an order for hospice. Median time from PCC to death was shorter among White than Black decedents (46.5 vs 101.3 days. Nearly 10% (n=123) of individuals experienced an ICU stay and 5% (n=58) died in-hospital.

In an unadjusted model, Black individuals were more likely to receive PCCs (adjusted Prevalence Ratio(aPR) 1.68; 95%CI 1.35–2.07) and a hospice order (aPR 1.47, 95% CI 1.1–1.9) relative to White individuals. However, these results were no longer statistically significant after adjusting for ICU use. (Table 2 and Supplemental Table 1)

Table 2:

Prevalence Ratios of Palliative Care Consultation and Hospice Order by Race

Palliative Care Consultation Hospice Order
Variables Unadjusted Adjusted Unadjusted Adjusted
OR 95% CI aOR 95% CI OR 95% CI aOR 95% CI
Sex
 Female Ref Ref Ref Ref
 Male 1.02 .833–1.25 1.05 .879–1.26 .821 .637–1.06 .922 .723–1.18
Race
White Ref Ref Ref Ref
Black 1.68*** 1.35–2.07 1.05 .851–1.29 1.47** 1.11–1.93 .830 .614–1.12
Age at death
 ≤54 Ref Ref Ref Ref
 55–64 1.19 .500–2.60 .661 .272–1.61 1.70 .428–6.71 1.87 .407–8.55
 65–79 1.10 .494–2.43 .998 .412–2.42 1.77 .463–6.79 1.77 .395–7.96
 80 + 1.23 .552–2.72 1.02 .418–2.48 2.60 .650–9.91 2.37 .525–10.66
Marital Status
 Married Ref Ref Ref Ref
 Single 1.26 .928–1.71 1.02 .747–1.38 1.57* 1.08–2.29 1.43 .982–2.08
 Divorced/Separated .953 .674–1.35 .804 .598–1.08 1.30 .867–1.94 1.15 .787–1.69
 Widowed 1.30* 1.01–1.65 1.16 .929–1.44 1.81*** 1.35–2.43 1.37* 1.03–1.83
 Unknown .678 .352–1.31 1.08 .618–1.89 .275 .070–1.09 .437 .109–1.75
Insurance
 Private Ref Ref Ref Ref
 Medicare 1.25* 1.01–1.55 1.35 .938–1.37 1.51** 1.15–1.98 1.30* 1.01–1.68
 Medicaid .924 .546–1.57 .968 .604–1.55 .712 .324–1.56 .786 .354–1.74
 Other .255*** .147–.444 .453** .273–.750 .212*** .099–.454 .432* .207–.904
Rural Urban
Metropolitan Ref Ref Ref Ref
Micropolitan .306*** .176–.531 .469** .277–.750 .139*** .052–.369 .237** .094–.600
Small town 1.09 .551–2.16 .837 .492–1.42 1.24 .571–2.70 1.10 .639–1.91
Rural .955 .406–2.25 .995 .524–1.89 .652 .177–2.40 .702 .246–2.00
Social Deprivation
Quartile 1 (SDI 1–25) Ref Ref Ref Ref
Quartile 2 (SDI 26–50) .783 .567–1.08 .846 .637–1.12 .802 .548–1.17 .866 .613–1.23
Quartile 3 (SDI 51–75) .825 .615–1.12 .977 .760–1.26 .711 .496–1.02 .880 .635–1.22
Quartile 4 (SDI 76–100) .883 .653–1.19 .877 .663–1.16 .804 .556–1.16 .884 .614–1.27
ICU use in last 30 days 5.39*** 4.64–6.26 3.65*** 3.04–4.38 4.75*** 3.82–5.92 3.24*** 2.51–4.19
Spiritual Care Consult 4.01*** 3.24–4.94 2.60*** 2.10–3.22 4.42*** 3.39–5.76 2.73*** 2.06–3.62
Year of Death .946 .881–1.01 1.02 .955–1.08 .883** .810-.963 .940 .865–1.02

Table is based on Poisson regression models assessing the association of decedent characteristics and each EOL outcome. Models were adjusted for sex, age at death, marital status, insurance status, rurality, social deprivation, spiritual care consult, and ICU utilization. White decedents are the reference. In the regression, miscellaneous and no recorded insurance were combined as only 8 individuals were reported to have miscellaneous insurance.

Discussion

In this cohort of COPD decedents, Black individuals were more likely to receive PCCs and hospice orders than White individuals; however, after adjusting for ICU use, Black race was no longer a significant predictor of PCC or hospice order. Decedents in our sample had fewer hospitalizations and ICU stays but more hospice orders than in prior cohort studies of COPD decedents.13,23

The need for ICU care may be a driver of PCC at the EOL. In our cohort, Black individuals were more likely to receive ICU care at the end-of-life. These findings may, in part, be driven by patient preferences, as that Black individuals have been shown to prefer more aggressive care at the EOL.24 Greater use of intensive care near EOL among Black individuals may prompt PCCs for goals-of-care conversations and caregiver support.25,26 ICU clinicians may have limited confidence, time, and skills to conduct goals-of-care conversations.27 Our findings may also indicate recognition of the disparate symptom burden and palliative needs among Black individuals with COPD.

Limitations include generalizability of findings as our data were from one health system, though greater receipt of PCCs has been observed in Black individuals with cancer and heart failure from various geographic regions and health systems.22,25,28 Other limitations include a lack of measures of disease severity, reasons for PCC, and patient preferences regarding end-of-life care. While identifying COPD via ICD codes has low sensitivity compared with manual chart review, 29 adding an age cutoff and selecting decedents with documented spirometry increases the diagnostic accuracy in this sample. Additionally, there were too few decedents of other racial groups to include in the analysis. Although ICD codes have limitations in identifying PCC in electronic medical records, all decedents in our sample had documented PC encounters.30,31

We found that fewer than a quarter of COPD decedents received PCCs, with earlier receipt observed among Black decedents. PC remains underutilized in COPD and efforts to increase early PCCs in COPD among all patients are needed.

Supplementary Material

1

Highlights.

  • Black individuals with COPD are equally likely to receive palliative care as White individuals.

  • Intensity of end-of-life care may be a driver of racial disparities in palliative care use.

  • Median time from palliative care consultation to death is shorter among White vs Black individuals.

  • Most decedents with COPD who receive palliative care do so within the two months prior to death.

Funding:

NS was supported by the NIH-funded CTSA grant (UL1TR002378) and the CHEST Foundation COPD Research Grant. SHC was supported by the NIH-funded Georgia CTSA KL2 and UL1 grants (KL2TR002381 and UL1TR002378). DK was supported by the Cystic Fibrosis Foundation and the NHLBI (R01 HL171735).

Footnotes

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Iyer AS, Dionne-Odom JN, Ford SM, et al. A Formative Evaluation of Patient and Family Caregiver Perspectives on Early Palliative Care in Chronic Obstructive Pulmonary Disease across Disease Severity. Ann Am Thorac Soc. Aug 2019;16(8):1024–1033. doi: 10.1513/AnnalsATS.201902-112OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Maddocks M, Lovell N, Booth S, Man WD, Higginson IJ. Palliative care and management of troublesome symptoms for people with chronic obstructive pulmonary disease. Lancet. Sep 2 2017;390(10098):988–1002. doi: 10.1016/s0140-6736(17)32127-x [DOI] [PubMed] [Google Scholar]
  • 3.Iyer AS, Sullivan DR, Lindell KO, Reinke LF. The Role of Palliative Care in COPD. Chest. May 2022;161(5):1250–1262. doi: 10.1016/j.chest.2021.10.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Curtis JR. Palliative and end-of-life care for patients with severe COPD. Eur Respir J. Sep 2008;32(3):796–803. doi: 10.1183/09031936.00126107 [DOI] [PubMed] [Google Scholar]
  • 5.Celli BR, MacNee W, Force AET. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. Jun 2004;23(6):932–46. doi: 10.1183/09031936.04.00014304 [DOI] [PubMed] [Google Scholar]
  • 6.Agusti A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Am J Respir Crit Care Med. Apr 1 2023;207(7):819–837. doi: 10.1164/rccm.202301-0106PP [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Selecky PA, Eliasson CA, Hall RI, et al. Palliative and end-of-life care for patients with cardiopulmonary diseases: American College of Chest Physicians position statement. Chest. Nov 2005;128(5):3599–610. doi: 10.1378/chest.128.5.3599 [DOI] [PubMed] [Google Scholar]
  • 8.Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. Dec 2000;55(12):1000–6. doi: 10.1136/thorax.55.12.1000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Brown CE, Jecker NS, Curtis JR. Inadequate Palliative Care in Chronic Lung Disease. An Issue of Health Care Inequality. Ann Am Thorac Soc. Mar 2016;13(3):311–6. doi: 10.1513/AnnalsATS.201510-666PS [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Organization NHaPC. Facts and Figures 2022 Edition. https://www.nhpco.org/wp-content/uploads/NHPCO-Facts-Figures-2022.pdf
  • 11.Cross SH, Ely EW, Kavalieratos D, Tulsky JA, Warraich HJ. Place of Death for Individuals With Chronic Lung Disease: Trends and Associated Factors From 2003 to 2017 in the United States. Chest. Aug 2020;158(2):670–680. doi: 10.1016/j.chest.2020.02.062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Cross SH, Warraich HJ. Changes in the Place of Death in the United States. N Engl J Med. Dec 12 2019;381(24):2369–2370. doi: 10.1056/NEJMc1911892 [DOI] [PubMed] [Google Scholar]
  • 13.Au DH, Udris EM, Fihn SD, McDonell MB, Curtis JR. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med. Feb 13 2006;166(3):326–31. doi: 10.1001/archinte.166.3.326 [DOI] [PubMed] [Google Scholar]
  • 14.Han MK, Curran-Everett D, Dransfield MT, et al. Racial differences in quality of life in patients with COPD. Chest. Nov 2011;140(5):1169–1176. doi: 10.1378/chest.10-2869 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Eisner MD, Blanc PD, Omachi TA, et al. Socioeconomic status, race and COPD health outcomes. J Epidemiol Community Health. Jan 2011;65(1):26–34. doi: 10.1136/jech.2009.089722 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. European Respiratory Journal. 2022;60(1):2101499. doi: 10.1183/13993003.01499-2021 [DOI] [PubMed] [Google Scholar]
  • 17.Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2021. Accessed September 3, 2021. https://goldcopd.org/2021-gold-reports/
  • 18.Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. Aug 2 2011;155(3):179–91. doi: 10.7326/0003-4819-155-3-201108020-00008 [DOI] [PubMed] [Google Scholar]
  • 19.Service UDoAER. Rural-Urban Commuting Area Codes. https://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes/
  • 20.Center RG. Social Deprivation Index (SDI). https://www.graham-center.org/maps-data-tools/social-deprivation-index.html
  • 21.Butler DC, Petterson S, Phillips RL, Bazemore AW. Measures of social deprivation that predict health care access and need within a rational area of primary care service delivery. Health Serv Res. Apr 2013;48(2 Pt 1):539–59. doi: 10.1111/j.1475-6773.2012.01449.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Cross SH, Yabroff KR, Yeager KA, et al. Social Deprivation and End-of-Life Care Use Among Adults With Cancer. JCO Oncol Pract. Nov 20 2023:OP2300420. doi: 10.1200/OP.23.00420 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Iyer AS, Goodrich CA, Dransfield MT, et al. End-of-Life Spending and Healthcare Utilization Among Older Adults with Chronic Obstructive Pulmonary Disease. Am J Med. Jul 2020;133(7):817–824.e1. doi: 10.1016/j.amjmed.2019.11.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.LoPresti MA, Dement F, Gold HT. End-of-Life Care for People With Cancer From Ethnic Minority Groups: A Systematic Review. Am J Hosp Palliat Care. Apr 2016;33(3):291–305. doi: 10.1177/1049909114565658 [DOI] [PubMed] [Google Scholar]
  • 25.Sharma RK, Cameron KA, Chmiel JS, et al. Racial/Ethnic Differences in Inpatient Palliative Care Consultation for Patients With Advanced Cancer. J Clin Oncol. Nov 10 2015;33(32):3802–8. doi: 10.1200/JCO.2015.61.6458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Muni S, Engelberg RA, Treece PD, Dotolo D, Curtis JR. The influence of race/ethnicity and socioeconomic status on end-of-life care in the ICU. Chest. May 2011;139(5):1025–1033. doi: 10.1378/chest.10-3011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bernacki RE, Block SD. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med. Dec 2014;174(12):1994–2003. doi: 10.1001/jamainternmed.2014.5271 [DOI] [PubMed] [Google Scholar]
  • 28.Cross SH, Dickert NW, Morris AA, Taj J, Ogunniyi MO, Kavalieratos D. Racial Differences in Palliative Care Use in Heart Failure Decedents. J Card Fail. Mar 14 2024;doi: 10.1016/j.cardfail.2024.02.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Stein BD, Bautista A, Schumock GT, et al. The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest. Jan 2012;141(1):87–93. doi: 10.1378/chest.11-0024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hua M, Li G, Clancy C, Morrison RS, Wunsch H. Validation of the V66.7 Code for Palliative Care Consultation in a Single Academic Medical Center. J Palliat Med. Apr 2017;20(4):372–377. doi: 10.1089/jpm.2016.0363 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Feder SL, Redeker NS, Jeon S, et al. Validation of the ICD-9 Diagnostic Code for Palliative Care in Patients Hospitalized With Heart Failure Within the Veterans Health Administration. Am J Hosp Palliat Care. Jul 2018;35(7):959–965. doi: 10.1177/1049909117747519 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES